Trial intelligence / Profile preview

E004 (Epinephrine HFA) Dose-Ranging in Asthma

NCT01025648Phase 2Terminated

Start
Dec 2009
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Primatene Mist in asthma. Started Dec 2009; status: terminated.

02

Drugs

Primatene Mist
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01025648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01025648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call